ContraFect
CFRX
#10568
Rank
$0.53 M
Marketcap
$0.05000
Share price
-27.95%
Change (1 day)
-97.77%
Change (1 year)

Revenue for ContraFect (CFRX)

Revenue in 2023 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ContraFect from 2013 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Viking Therapeutics
VKTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
$75.36 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Prometheus Biosciences
RXDX
$3.99 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA